Intracytoplasmic Sperm Injection (ICSI) is a sperm micromanipulation technique—a laboratory procedure that uses an extremely fine needle to inject a single sperm directly into an egg. Unlike conventional fertilization methods, ICSI bypasses the natural selection process by directly injecting a single sperm cell. Although it offers a higher certainty of fertilization in certain cases, its use requires strict clinical evaluation before application.
Difference in Mechanism: ICSI versus Conventional IVF
In a conventional IVF program, the fertilization process closely mimics the natural method. Mature oocytes (eggs ready to be fertilized) are placed together with tens of thousands of sperm in a laboratory culture dish. These sperm must independently compete to penetrate the cumulus cells (the protective cell layer surrounding the egg) and the zona pellucida—the outermost protective layer of the egg that the sperm must breach to fertilize it.
In ICSI, all these physical barriers are bypassed. A specific enzyme (hyaluronidase—an enzyme that dissolves the protective cell layer around the egg) is used to strip the cumulus cells so that the maturity level of the oocyte can be assessed. Only mature oocytes (metaphase II phase—the stage of egg maturity ready for fertilization) are eligible for ICSI. The embryologist then selects a single sperm, immobilizes its tail movement, and injects it through the oolemma (the egg’s outermost membrane) directly into the cytoplasm (the inner part of the egg where the sperm’s genetic material will fuse).
Medical Indications for ICSI Based on Global Consensus
According to the ASRM clinical guidelines, ICSI is not intended as a standard procedure for all IVF patients, but rather should be restricted to specific medical indications that have proven to benefit from it:
- Severe Male Factor Infertility: Extreme oligozoospermia (very low sperm count), severe asthenozoospermia (very poor sperm motility), or absolute teratozoospermia (almost all sperm have abnormal morphology).
- Use of Surgically Retrieved Sperm: Sperm retrieved from testicular or epididymal tissue through microsurgical procedures such as micro-TESE or PESA (Percutaneous Epididymal Sperm Aspiration—retrieving sperm from the epididymis using a needle without an open incision) are not yet capable of penetrating the zona pellucida naturally, hence mandatory fertilization via ICSI.
- History of Total Fertilization Failure: Couples who previously experienced total fertilization failure in a conventional IVF cycle despite apparently normal sperm parameters.
- Use of PGT (Preimplantation Genetic Testing): Genetic testing on embryos before uterine transfer to detect chromosomal abnormalities or genetic diseases. ICSI is mandatory to avoid contamination from residual DNA of other sperm clinging outside the zona pellucida.
- Severe Idiopathic Infertility: Idiopathic infertility—a condition where a couple fails to conceive despite all test results appearing normal and no clear cause found. ICSI may be considered in selected cases.
It is important to note that isolated teratospermia—a condition where only sperm morphology is abnormal without accompanying reductions in sperm count or motility—is not a medical indication for ICSI and has not been shown to improve live birth rates.
Controversy Over ICSI Use Without Male Factor Indications
Globally, there has been an increase in the use of ICSI in non-male factor cases (infertility where the cause is not from the male partner). Data from the Centers for Disease Control and Prevention (CDC) in the United States show that 68–72% of cycles without male factor infertility use ICSI routinely. However, clinical evidence does not support this trend.
A study analyzing 140,252 egg retrieval cycles demonstrated that the cLBR (Cumulative Live Birth Rate—the percentage of pregnancies resulting in a live birth after all embryo transfer cycles) was actually higher in the conventional IVF group (38.5%) compared to the ICSI group (36.3%)—a statistically highly significant difference. Furthermore, ICSI without male factor indications is associated with a lower implantation rate (23.0% vs. 25.2%) and a higher failure rate of embryo development to the blastocyst stage (the developmental stage of the embryo around day 5, ready for implantation).
Although ICSI yields a higher fertilization rate in sibling oocytes—eggs from the same retrieval divided into two groups, some fertilized with ICSI and others with conventional IVF, for direct comparison in cases of unexplained infertility (65.3% vs. 48.1%), this does not correlate with an improvement in final embryo quality or live birth rate. The use of ICSI without clear medical indications risks lowering cycle success potential while simultaneously increasing the patient’s financial burden.
Fertilization Success Evaluation and Biological Safety Profile
ICSI can produce a stable fertilization rate ranging from 50–80% per injected mature oocyte. However, this mechanical procedure carries the risk of cellular trauma—about 5–10% of oocytes can experience structural damage or lysis (permanent cell rupture and destruction) directly due to microneedle penetration.
From the aspect of child safety, children born via ICSI have a slightly higher risk of major birth defects compared to natural conception (ranging from 1.5–3%). Abnormalities reported in less than 1% of ICSI births include sex chromosome abnormalities, hypospadias (a congenital condition where the urethral opening is not at the tip of the penis), and genomic imprinting disorders—genetic mechanisms where specific genes are only active from one parent; disruptions to this mechanism can cause certain syndromes such as Angelman and Beckwith-Wiedemann syndromes. Current medical consensus believes that this increased risk is predominantly influenced by inherited genetic infertility factors from the parents, rather than the ICSI procedure itself.
Comparison of Conventional IVF vs. ICSI
Aspect
Conventional IVF
ICSI (Microinjection)
Impact on Patient
Fertilization Method
Natural penetration by tens of thousands of sperm in a dish
Mechanical injection of a single sperm directly into the egg
Bypasses functional failures of egg shell penetration
Implantation Chance (Non-Male Factor)
Higher (25.2%)
Lower (23.0%)
Using ICSI without indication may reduce success chances
Cumulative Live Birth Rate
Superior (38.5%)
Lower (36.3%)
Avoiding unnecessary invasive procedures can save costs
Physical Risk to Egg
Very minimal (non-invasive)
Egg damage or lysis 5–10%
Requires highly trained embryologists
Genetic Abnormality Risk
Equivalent to general population
Risk <1% (Beckwith-Wiedemann, Angelman syndromes)
Genetic counseling before the procedure is recommended for severe male factor cases
Next Steps
If you are planning an IVF program, discuss with your doctor whether you truly need ICSI or if the conventional IVF method is more recommended for your condition.
HagiaMed Free Consultation — a complimentary initial consultation with our specialists, at no cost and with no obligation.
References
• Intracytoplasmic Sperm Injection (ICSI) | TRM | Chattanooga, TN.
• Intracytoplasmic sperm injection for non-male factor infertility does not improve cumulative live birth rate: a Canadian assisted reproductive technologies registry (CARTR Plus) descriptive study. Frontiers.
• Intracytoplasmic sperm injection for nonmale factor indications: a Committee opinion (2026). ASRM.
• Intracytoplasmic sperm injection (ICSI) patient education fact sheet. ReproductiveFacts.org.
Disclaimer: This information is for educational purposes and does not replace a physician’s evaluation. Diagnostic and therapeutic decisions should be tailored to the examination results of you and your partner.
